dm+d
Unassigned
New Medicines
ViramidineHepatitis C infection
Information
Viramidine
New molecular entity
Valeant
Valeant
Development and Regulatory status
Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials
Jan 16. Not listed in company pipeline. PIII studies completed some years ago and no current studies ongoing [5].
Category
Nucleoside (guanosine) analogue prodrug of ribavirin
Estimated to be ~173,000 chronically infected HCV patients in England and Wales, of which ~ 28,800 are diagnosed. ~ 17,000 HCV patients are currently treated and 45% of these (7,650) are genotype 1; it is assumed that the majority are currently treatment naive (90% in 2011).
Hepatitis C infection
Oral